32.71
price down icon2.12%   -0.71
after-market アフターアワーズ: 32.50 -0.21 -0.64%
loading
前日終値:
$33.42
開ける:
$33.8
24時間の取引高:
50,382
Relative Volume:
0.97
時価総額:
$224.63M
収益:
-
当期純損益:
$-4.98M
株価収益率:
-24.82
EPS:
-1.3177
ネットキャッシュフロー:
$-3.85M
1週間 パフォーマンス:
-1.21%
1か月 パフォーマンス:
-9.11%
6か月 パフォーマンス:
-33.16%
1年 パフォーマンス:
+2,901%
1日の値動き範囲:
Value
$32.00
$33.82
1週間の範囲:
Value
$31.10
$35.94
52週間の値動き範囲:
Value
$0.93
$79.02

Bright Minds Biosciences Inc Stock (DRUG) Company Profile

Name
名前
Bright Minds Biosciences Inc
Name
セクター
Healthcare (1154)
Name
電話
-
Name
住所
-
Name
職員
0
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
DRUG's Discussions on Twitter

DRUG を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
DRUG
Bright Minds Biosciences Inc
32.71 224.63M 0 -4.98M -3.85M -1.3177
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.84 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
602.64 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.76 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.56 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
244.90 24.70B 3.81B -644.79M -669.77M -6.24

Bright Minds Biosciences Inc Stock (DRUG) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-01-23 開始されました Piper Sandler Overweight
2025-01-10 開始されました Cantor Fitzgerald Overweight
2025-01-10 開始されました H.C. Wainwright Buy
2024-11-26 開始されました Robert W. Baird Outperform

Bright Minds Biosciences Inc (DRUG) 最新ニュース

pulisher
06:10 AM

Piper Sandler sets $93 target for Bright Minds Biosciences stock - MSN

06:10 AM
pulisher
Apr 22, 2025

Uncover the Best-Performing Canadian Biotech Stocks of 2025 - Investing News Network

Apr 22, 2025
pulisher
Apr 22, 2025

When (DRUG) Moves Investors should Listen - news.stocktradersdaily.com

Apr 22, 2025
pulisher
Apr 16, 2025

Bright Minds Biosciences: A Buy With A Major Catalyst In Q2 2025 (NASDAQ:DRUG) - Seeking Alpha

Apr 16, 2025
pulisher
Apr 03, 2025

Reviewing Allarity Therapeutics (NASDAQ:ALLR) & Bright Minds Biosciences (NASDAQ:DRUG) - Defense World

Apr 03, 2025
pulisher
Apr 01, 2025

Discover the Top 5 Small-Cap Biotech Stocks in 2025 - Investing News Network

Apr 01, 2025
pulisher
Mar 26, 2025

(DRUG) Trading Advice - news.stocktradersdaily.com

Mar 26, 2025
pulisher
Mar 21, 2025

Bright Minds Biosciences Inc. (NASDAQ:DRUG) Sees Significant Decrease in Short Interest - Defense World

Mar 21, 2025
pulisher
Mar 18, 2025

DRUG FY2025 EPS Estimate Decreased by Cantor Fitzgerald - The AM Reporter

Mar 18, 2025
pulisher
Mar 18, 2025

Cantor Fitzgerald Has Weak Forecast for DRUG FY2025 Earnings - Defense World

Mar 18, 2025
pulisher
Mar 15, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Trading Down 0.8% – Here’s Why - Defense World

Mar 15, 2025
pulisher
Mar 09, 2025

Bright Minds Biosciences Independent Director Nils Bottler Sells 100% Of Holding - simplywall.st

Mar 09, 2025
pulisher
Mar 04, 2025

Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Leaders in Epilepsy Research - GlobeNewswire

Mar 04, 2025
pulisher
Mar 04, 2025

Bright Minds Biosciences Strengthens Epilepsy Focus with New Advisory Board Members - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Can These 5 Epilepsy Experts Accelerate Bright Minds' Breakthrough Drug Development? - StockTitan

Mar 04, 2025
pulisher
Mar 04, 2025

DRUGBright Minds Biosciences Inc Latest Stock News & Market Updates - Stock Titan

Mar 04, 2025
pulisher
Feb 24, 2025

Bright Minds Biosciences to Participate at Three Healthcare Conferences in March - The Manila Times

Feb 24, 2025
pulisher
Feb 24, 2025

Can This CNS Drug Developer's Triple Conference Tour Spark Investor Interest? - StockTitan

Feb 24, 2025
pulisher
Feb 23, 2025

How the (DRUG) price action is used to our Advantage - news.stocktradersdaily.com

Feb 23, 2025
pulisher
Feb 22, 2025

HC Wainwright Issues Negative Estimate for DRUG Earnings - Defense World

Feb 22, 2025
pulisher
Feb 21, 2025

H.C. Wainwright maintains $85 target on Bright Minds stock By Investing.com - Investing.com Nigeria

Feb 21, 2025
pulisher
Feb 20, 2025

H.C. Wainwright maintains $85 target on Bright Minds stock - Investing.com India

Feb 20, 2025
pulisher
Feb 20, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Given “Buy” Rating at HC Wainwright - Defense World

Feb 20, 2025
pulisher
Feb 19, 2025

Bright Minds Biosciences’ BMB-101: A Promising Contender in Serotonergic Epilepsy Treatment with Strong Market Potential - TipRanks

Feb 19, 2025
pulisher
Feb 14, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Announces Earnings Results, Beats Estimates By $0.24 EPS - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

Bright Minds Biosciences Dramatic Surge Highlights the High-Stakes Nature of Biotech Investments - HPBL

Feb 14, 2025
pulisher
Feb 14, 2025

BriaCell Therapeutics: A Biotech Stock on the Brink of a Turnaround? - HPBL

Feb 14, 2025
pulisher
Feb 14, 2025

Biotechs on the Brink: 2 Stocks With Huge Potential - Benzinga

Feb 14, 2025
pulisher
Feb 14, 2025

Bright Minds Biosciences Shows Financial Improvement in Latest Report - TipRanks

Feb 14, 2025
pulisher
Feb 05, 2025

SEC Form F-3 filed by Bright Minds Biosciences Inc. - Quantisnow

Feb 05, 2025
pulisher
Feb 04, 2025

More Money In The Bank For Bright Minds Biosciences Insiders Who Divested CA$16m - Simply Wall St

Feb 04, 2025
pulisher
Feb 04, 2025

How To Buy Bright Minds Biosciences Inc. Stock Online in February 2025 - Traders Union

Feb 04, 2025
pulisher
Jan 31, 2025

Long Term Trading Analysis for (DRUG) - Stock Traders Daily

Jan 31, 2025
pulisher
Jan 26, 2025

Bright Minds Biosciences: Looking To Change Scope Of Epilepsy Disorder Treatments With BMB-101 - Seeking Alpha

Jan 26, 2025
pulisher
Jan 26, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Research Coverage Started at Piper Sandler - Defense World

Jan 26, 2025
pulisher
Jan 24, 2025

Piper Sandler Initiates Coverage of Bright Minds Biosciences (DRUG) with Overweight Recommendation - MSN

Jan 24, 2025
pulisher
Jan 24, 2025

Piper Sandler sets $93 target for Bright Minds Biosciences stock By Investing.com - Investing.com South Africa

Jan 24, 2025
pulisher
Jan 24, 2025

Cantor Fitzgerald Predicts DRUG FY2025 Earnings - Defense World

Jan 24, 2025
pulisher
Jan 23, 2025

Cantor Fitzgerald Comments on DRUG FY2025 Earnings - MarketBeat

Jan 23, 2025
pulisher
Jan 23, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Now Covered by Analysts at Piper Sandler - MarketBeat

Jan 23, 2025
pulisher
Jan 23, 2025

This Prudential Financial Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday - Benzinga

Jan 23, 2025
pulisher
Jan 22, 2025

5-HT2 Agonist Clinical Trial Pipeline Appears Robust With - GlobeNewswire

Jan 22, 2025
pulisher
Jan 21, 2025

Learn to Evaluate (DRUG) using the Charts - Stock Traders Daily

Jan 21, 2025
pulisher
Jan 16, 2025

Bright Minds Biosciences Appoints New Chief Medical Officer to Advance CNS Therapeutics - MSN

Jan 16, 2025
pulisher
Jan 14, 2025

Head-To-Head Analysis: Bright Minds Biosciences (NASDAQ:DRUG) versus Enlivex Therapeutics (NASDAQ:ENLV) - Defense World

Jan 14, 2025
pulisher
Jan 12, 2025

Cantor Fitzgerald Begins Coverage on Bright Minds Biosciences (NASDAQ:DRUG) - Defense World

Jan 12, 2025
pulisher
Jan 12, 2025

HC Wainwright Begins Coverage on Bright Minds Biosciences (NASDAQ:DRUG) - Defense World

Jan 12, 2025

Bright Minds Biosciences Inc (DRUG) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
大文字化:     |  ボリューム (24 時間):